
China is building a giant laser facility to master near-limitless clean energy, satellite images appear to show
Images from space reveal an enormous X-shaped building rising up from rocky terrain in southwestern China. This is a huge nuclear fusion research facility, analysts say, and it could be a sign China is leaping ahead in the quest to harness this futuristic energy source.
It could also mean they are amping up nuclear weapons development.
Decker Eveleth, an analyst at US-based research organization the CNA Corporation, has been among those watching this facility for years. In 2020, a US official released images purporting to show various potential Chinese nuclear locations, including the site near Mianyang in Sichuan province.
At this point, it was basically 'a patch of dirt,' Eveleth told CNN. But after Covid shutdowns were lifted, construction accelerated. The project is described as a 'laser fusion' facility in contract documents obtained by Eveleth and seen by CNN.
If the facility is indeed a laser facility, it will offer a unique way of studying materials in extreme conditions. It allows scientists to create 'pressures that are typically found in the center of stars or in nuclear weapons,' said Brian Appelbe, a research fellow from the Centre for Inertial Fusion Studies at Imperial College London.
Eveleth says the four giant arms shown in the satellite image are 'bays' which will be able to shoot lasers at the tall, central tower, which houses a target chamber containing hydrogen isotopes. The laser energy fuses the hydrogen together to create a burst of energy in a process called ignition.
Nuclear fusion offers the tantalizing prospect of abundant, clean energy without the long-lived radioactive waste problem of nuclear fission, the world's current nuclear energy technology. Countries and companies across the world are in a race to master it.
The US has long been a leader. The National Ignition Facility in California, which also uses laser-ignition technology, made a huge fusion energy breakthrough in 2022. In a world first, NIF scientists achieved a successful nuclear fusion reaction with a net energy gain (although they didn't count the energy needed to power the lasers).
It was a big step forward in the decades-long quest to recreate on Earth the reaction which powers the sun and other stars. But this new facility in China could be a sign China is starting to to edge ahead.
'It signals that they are serious about fusion' said Melanie Windridge, CEO of Fusion Energy Insights, an industry monitoring organization. 'They are being decisive, moving quickly and getting things done.'
Eveleth estimates China's Mianyang research center will be around 50% bigger than the United States' NIF and, once completed, likely the biggest facility of its kind in the world.
Its size could have advantages. A larger laser allows higher pressures and more material can be compressed, potentially increasing the energy achieved from nuclear fusion experiments, Appelbe told CNN. Although, he cautioned, achieving a successful fusion experiment is 'extremely challenging' even with a very large laser.
CNN contacted China's Ministries of National Defense and of Science and Technology for comment but had not heard back at the time of publication.
Experts say the facility also gives China the ability to research nuclear weapons.
China and the US are both parties to the Comprehensive Nuclear Test Ban Treaty, which prohibits nuclear explosions.
The level of energy unleashed by nuclear weapons is very difficult to simulate with computers and other conventional methods. This is where laser-ignition fusion facilities can help, Eveleth said. They can shine high-powered lasers onto various materials to simulate the conditions in the first few microseconds after a nuclear explosion.
'Any country with an NIF-type facility can and probably will be increasing their confidence and improving existing weapons designs,' William Alberque, a nuclear policy analyst at the Henry L. Stimson Centre, told Reuters.
A positive interpretation of the facility is that it provides reassurance China isn't planning any explosive nuclear testing, Eveleth said. But, he added, it could also allow them to develop more sophisticated designs, including smaller nuclear weapons.
Some experts believe the Mianyang site may end being a different kind of fusion facility, a hybrid of fusion and fission.
'If this proves to be true, it is particularly alarming,' said Andrew Holland, chief executive of the Fusion Industry Association. This would be homegrown Chinese tech and 'likely more powerful than anything of that type in Western countries.'
Regardless, the facility 'is clearly part of an ambitious program,' Holland told CNN.
The US is still ahead in the fusion race for now, he added, but 'China is moving fast' and has shown it can move from concept to completion much faster than any government programs.
'It is time to build, it is time to invest,' Holland said. 'If the US and its allies do not, then China will win this race.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
31 minutes ago
- Business Upturn
HistoSonics and Cambridge University Unveil Europe's First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
MINNEAPOLIS, United States: HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today that Addenbrookes Hospital of Cambridge University Hospital Foundation and Trust will be the first site in the United Kingdom and European continent to offer histotripsy to both NHS and private patients. This was made possible through a generous donation by the Li Ka Shing Foundation (LKSF) as well as the expedited limited market access granted by the MHRA in April 2025. This press release features multimedia. View the full release here: The milestone marks HistoSonics' official entry into the UK and European market. HistoSonics won a coveted place in the Innovative Device Access Pathway pilot in 2024 and through this program, in partnership with the DHSC, MHRA, NIHR, NHSE, and NICE expedited access to patients. HistoSonics will continue to work with UK healthcare stakeholders on our aligned goal of urgently expanding access for all NHS patients. The Li Ka Shing Foundation, established in 1980 by Hong Kong philanthropist Sir Ka-shing Li, has contributed nearly US$4 billion to advancing education, medical research and services, and poverty alleviation across the USA, UK, Canada, and Asia. Recognizing the transformative potential of technological innovation in healthcare, the Foundation's latest gift to the University of Cambridge will build upon its previous donations of five Edison systems with three to Hong Kong, one to Singapore, and one recently to Stanford University. This new gift not only heralds the introduction of the first Edison system in the UK and Europe but also celebrates the enduring partnership between the Li Ka Shing Foundation and Cambridge in their collaborative efforts to fight cancer. By supporting cutting-edge medical technologies that can deliver low cost and highly efficient solutions, the Foundation hopes to enhance patient access with improved healthcare around the world. 'This donation is an historic milestone that brings non-invasive treatment of liver tumors using histotripsy to the UK,' said Mike Blue, President and CEO, HistoSonics. 'We are grateful to the Li Ka Shing Foundation for their visionary support. With Addenbrookes as our first NHS hospital site under UCNA, we are laying the foundation for future expansion into innovation driven hospitals across the UK.' The Edison System, which received FDA De Novo clearance in October 2023, uses non-invasive therapeutic focused ultrasound energy to mechanically destroy and liquefy targeted tissue and tumors without the invasiveness or toxicity of traditional procedures, reducing the risks of bleeding, infection, and damage to surrounding non-targeted tissue. HistoSonics' initial FDA clearance is for the destruction of liver tumors, with ongoing studies focusing on kidney tumors (HOPE4KIDNEY Trial NCT05820087) and pancreas tumors (GANNON Trial NCT06282809). Professor Deborah Prentice, Vice-Chancellor of the University of Cambridge, said: 'We are very fortunate that through the generosity of Sir Ka-shing Li, Addenbrooke's Hospital in Cambridge will be able to use cutting-edge histotripsy technology to improve outcomes for NHS patients. It is technology such as this that allows Cambridge to remain at the forefront of understanding and treating tumors, a position we aim to strengthen further with Cambridge Cancer Research Hospital.' With installations soon to be in five countries including the US, UK, Hong Kong, Singapore and the United Arab Emirates, HistoSonics is actively expanding access to its histotripsy platform and is working closely with clinical leaders, national health systems, and philanthropic partners to accelerate global adoption of histotripsy as a new category of health care. HistoSonics is also pursuing broader UK and European market access via CE marking. United Kingdom Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumours, including the partial or complete destruction of unresectable liver tumours via histotripsy. This includes malignancy linked to primary liver cancer and cases of metastatic disease in the liver. The device should only be used by people who have completed training performed by HistoSonics Inc., and its use guided by the clinical judgement of an appropriately trained physician. Users must read this user guide to understand the warnings, precautions, and clinical trial summary, including reported adverse events. The Edison System has not been evaluated for the treatment of any specific disease, including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumour progression, 5-year survival or overall survival). United States Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by physicians who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions, and a summary of clinical trial results, including reported adverse events. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit: View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Yahoo
43 minutes ago
- Yahoo
CO2 levels just broke another record. Here's what that means
When man first walked on the moon, the carbon dioxide concentration in Earth's atmosphere was 325 parts per million (ppm). By 9/11, it was 369 ppm, and when COVID-19 shut down normal life in 2020, it had shot up to 414 parts ppm. This week, our planet hit the highest levels ever directly recorded: 430 parts per million. For 67 years, the observatory on Hawaii's Mauna Loa volcano has been taking these measurements daily — tracking the invisible gas that is building up in our atmosphere and changing life on Earth. The record is known as the Keeling Curve. Charles David Keeling began those recordings, some of the first in the world to measure CO2 concentration over time. His son, Ralph Keeling, born one year before the observatory opened, has witnessed the rapid increase firsthand over his lifetime. "I was a teenager when I first started to appreciate what my father was doing and how it might be significant," Keeling told CBC News. Back then it was around 330 ppm. Keeling, a geochemistry professor at Scripps Institution of Oceanography at the University of California, San Diego, took over the research once his father passed away in 2005. "This problem is not going away, and we're moving further and further into uncharted territory, and almost certainly, very dangerous territory." The build up of carbon dioxide in the atmosphere isn't visible to the naked eye, but its concentration matters because of the greenhouse effect. Like the glass walls that trap heat from the sun in an actual greenhouse, gases in our atmosphere such as CO2 and methane also trap heat from the sun. At the start of the Industrial Revolution, ice core samples show CO2 levels were around 280 parts per million but as they rose, warming has increased by about 1.3 C over the pre-industrial average. That's led to rising temperatures and leading to more frequent and extreme weather, like heat waves, floods, wildfires and droughts. While many have heard about the goals of limiting warming to 1.5 C or 2 C above pre-industrial levels, there have also been efforts to return CO2 levels to below 350 parts per million, as a key part of limiting the damage from climate change. The record highs have continued though. Just in the last year, CO2 readings from May have increased more than three parts per million — that many more molecules of CO2 trapping heat and contributing to warming. "We know why it's rising faster than ever, it's because we're burning more fossil fuels each year," said Keeling. Damon Matthews, a climate scientist and professor at Concordia University in Quebec, also says he's concerned and isn't surprised that there are new records every year. "If we want to actually stabilize CO2 levels in the atmosphere, we would need to cut global emissions by more than 50 per cent, and we're nowhere near doing that," he said, adding that there are other gases at play but CO2 is the dominant influence. "Every May, we're going to see a new record of atmospheric CO2, until we actually make a lot more progress on climate mitigation than we have today." The annual cycle, peaking in late spring in the northern hemisphere, is tied to plant photosynthesis — CO2 concentrations drop in the summer as plants absorb the gas and release oxygen. In 2021, the International Energy Agency said that if the world wants to limit global warming and reach net-zero by 2050, there could be no new coal, oil or gas projects. Matthews is part of Canada's net-zero advisory body and says he's seen some progress in decreasing CO2 emissions the last few years, but not enough. He says Europe's emissions have been going down for decades, and that last year CO2 emissions in China didn't increase. However, he says Canada still lags behind other countries, and the U.S. is trending the other way. "There's lots of policy options, certainly focusing on expanding the oil and gas industry in Canada right now is not going to get us where we need to go in terms of climate," he said. "We just need to stop arguing about whether it's a priority and start doing the things that we know will help to solve the problem."


Newsweek
an hour ago
- Newsweek
US Detains Chinese Scientist for 'Smuggling' Biological Material From Wuhan
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A Chinese scientist has been detained by U.S. authorities, accused of smuggling biological materials into the country from the city of Wuhan, the Department of Justice (DOJ) said on Monday. Chengxuan Han, a citizen of the People's Republic of China (PRC), has been charged in a criminal complaint with smuggling goods into the United States and making false statements. Newsweek has contacted the Chinese Embassy in Washington D.C. for comment by email. Why It Matters Han is the third Chinese national in recent days to be accused of smuggling biological materials into the country. On June 3, the DOJ said two Chinese nationals had allegedly smuggled in a fungus known as Fusarium graminearum, which causes a disease called "head blight." It infects major staple crops such as wheat, barley, maize, and rice. The DOJ did not specify what biological material Han allegedly smuggled into the U.S., but said it was "related to roundworms." A University Of Michigan North Campus sign in Ann Arbor on July 30, 2019. A University Of Michigan North Campus sign in Ann Arbor on July 30, To Know Han, a doctoral student at the College of Life Science and Technology at the Huazhong University of Science and Technology in Wuhan, arrived at Detroit Metropolitan Airport on a J1 visa, which is issued to people taking part in academic exchange programs, from Shanghai on Sunday. She is accused of sending four packages from China to individuals associated with a laboratory at the University of Michigan last year and this year containing "concealed biological material." Han was detained was arrested after Customs and Border Protection (CBP) officers conducted an inspection. The DOJ said Han made false statements during questioning about the packages and the biological materials she had previously shipped to the United States. "Han admitted to sending the packages, admitted that the packages contained biological material related to roundworms, and admitted to making false statements to the CBP officers during her inspection," the DOJ said. Investigators also said Han deleted the contents of her electronic device three days before she landed in the U.S. "A complaint is only a charge and is not evidence of guilt. [A] trial cannot be held on felony charges in a complaint. When the investigation is completed, a determination will be made whether to seek a felony indictment," the DOJ said. Last week, the DOJ accused Yunqing Jian, 33, and Zunyong Liu, 34, of smuggling in Fusarium Head Blight (FHB), which the department described as a "potential agroterrorism weapon." They were arrested and face charges of conspiracy, smuggling goods into the country, false statements, and visa fraud. FHB already poses a major threat to U.S. agriculture, causing nearly $3 billion in damage since the 1990s, Cornell University's Kerik Cox previously told Newsweek. Cox said that "strains of Fusarium graminearum can vary widely in aggressiveness." What People Are Saying United States Attorney Jerome F. Gorgon, Jr. said in a statement: "The alleged smuggling of biological materials by this alien from a science and technology university in Wuhan, China—to be used at a University of Michigan laboratory—is part of an alarming pattern that threatens our security. The American taxpayer should not be underwriting a PRC-based smuggling operation at one of our crucial public institutions." Cheyvoryea Gibson, special agent in charge of the FBI Detroit Field Office, said in a statement: "The FBI has zero tolerance for those who violate federal law and remains unwavering in our mission to protect the American people. "The alleged smuggling of biological materials by Chengxuan Han is a direct threat to public safety and national security, and it severely compromises the integrity of our nation's research institutions. CBP acting Director of Field Operations John Nowak said in a statement: "The guidelines for importing biological materials into the U.S. for research purposes are stringent, but clear, and actions like this undermine the legitimate work of other visiting scholars. "We will not tolerate the smuggling of regulated biological materials through our ports of entry, and this interdiction is another recent example of our commitment—along with that of our law enforcement partners—to preventing potentially dangerous goods from harming the American people." What Happens Next Han remains in custody ahead of a bond hearing on Wednesday.